Navigation Links
Diagnose in Biological Technology

Lumbar Matrix(TM) Scan From SpineMatrix(R) Revolutionizes the Diagnosis of Low Back Pain

... was developed to help physicians more precisely diagnose the cause of low back pain and prescribe the best ... images, which helps physicians to differentially diagnose lower back pain by identifying disc, facet and ... is dedicated to helping physicians accurately diagnose and treat patients with low back pain. Additional ...

Masimo Corporation Given Approval to Market the Masimo Rad-57 Pulse CO-Oximeter in Japan

... poisoning from CO is notoriously difficult to diagnose because its symptoms mirror those of lesser ... the Masimo Rad-57, the only method to accurately diagnose CO poisoning required inconvenient blood tests ... Medical School. "The ability to accurately diagnose and triage CO-poisoned victims at the scene can ...

Optherion, Inc. Completes $37 Million Start Up Financing

... Optherion, Inc., a company developing products to diagnose and treat dry and wet Age-related ... as well as a portfolio of tests that predict, diagnose and monitor progression of the disease. AMD is ... company that is developing products to diagnose and treat dry and wet Age-related ...

United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients

... to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases announced today that ... to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases. Its goals are to ...

Abbott HIV Test Demonstrates Earlier Disease Detection

... of the five panels tested. "The ability to use a blood test to diagnose HIV sooner, in the acute phase of the disease where antibodies are not yet ... incorporates HIV p24 antigen detection which enables laboratories to diagnose HIV infection before HIV antibodies are detectable. HIV p24 antigen is a ...

BD and FIND Achieve Milestone in Global Battle Against MDR-TB

... technical assistance, training and products that maximize the capacity to diagnose TB, including drug-resistant strains, in nations where the disease is most ... "With financial support from UNITAID, state-of-the-art technologies to diagnose MDR-TB are being introduced in low-income countries for the first time by ...

Study Finds Noninvasive Blood Test for Liver Fibrosis May Alleviate Need for Liver Biopsies for Some Patients with Chronic Hepatitis C

... liver fibrosis blood-serum test panel may help physicians more accurately diagnose and stage liver fibrosis in patients with chronic hepatitis C (HCV), ... blood-based biomarker testing used by physicians to screen for, diagnose and monitor carcinomas and other tissue-based disease. The company's ...

FDA Clears Boston Scientific's SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System

... throughout the entire pancreatico-biliary system, enabling physicians to diagnose and treat pancreatic cancer or pre-cancerous tissues. According to ... and deliver therapies such as laser and EHL. "Being able to diagnose pancreatic disease without the need for an invasive surgical procedure ...

Prometheus Receives New York State Approval for PROMETHEUS(R) IBS Diagnostic, First Blood Test for Irritable Bowel Syndrome

... are proprietary, along with a proprietary algorithm to help physicians diagnose patients with IBS. "One out of five Americans has symptoms of IBS, ... Pharmacology & Therapeutics ." IBS can be challenging to diagnose because it is a functional disease that is not associated with any visible ...

Artemis Health Licenses Prenatal Cell-Free DNA Analysis Technology from Stanford University

... non-invasive, safe and effective prenatal blood tests that accurately diagnose genetic disorders without the need for invasive tests like amniocentesis ... non-invasive, genome-based prenatal tests for use in early pregnancy to diagnose genetic abnormalities and chromosomal aneuploidies (abnormal number of ...

Bioheart, Inc. Announces Additional Funding Support

... to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, today announced ... to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases. Its goals are to ...

Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.

... physicians with two critical pieces of information they can use to diagnose heart health. First, by measuring time intervals on the ECG, doctors can ... to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases. Its goals are to ...

Bioheart, Inc. Announces Financial Results for Second Quarter 2008

... to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, today announced ... to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases. Its goals are to ...

Bioheart, Inc. Announces Results of Annual Meeting

... to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, announced the ... to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases. Its goals are to ...

Bioheart, Inc., Announces Management Change

... to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, announced today that ... to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases. Its goals are to ...

Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients

... to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, today announced it ... to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases. Its goals are to ...

Prometheus Licenses COLAL-PRED(R) From Alizyme

... therapeutic to our IBD Serology 7 diagnostic test, which helps physicians diagnose ulcerative colitis and Crohn's disease." Ulcerative colitis is an ... in the small intestine and colon. Ulcerative colitis can be difficult to diagnose because its symptoms are similar to other intestinal disorders and to ...

Time For the Trucking and Heavy Machinery Industries to Wake Up!

... during sleep to obtain the information necessary for a physician to diagnose OSA. The ARES can be conveniently self applied and worn while the ... implementing a program. --Inexpensive, accurate and convenient methods to diagnose OSA are now available. --Treatment options exist that can reduce the ...

W.M. Keck Foundation Awards $1 Million to Hutchinson Center Scholar to Study How Cells Go Awry

... Hutchinson Cancer Research Center , our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, ...

Cardinal Health Completes Biotech Acquisition

... These facilities are registered with the Food and Drug Administration (FDA) to manufacture PET imaging agents that are used by physicians to diagnose various medical conditions. With the addition of Biotech's four nuclear pharmacies, Cardinal Health will expand its existing U.S. PET ...

American Mothers Seriously Concerned About Childhood Allergies, Siemens Survey Reveals

... and perception of allergies and testing today. The survey is part of Siemens' ongoing campaign to educate parents about ways to better screen, diagnose and manage allergies. References: (1) "Chronic Conditions: A Challenge for the 21st Century," National Academy on an Aging ...

Blackrock Microsystems Obtains Expanded 510(k) to Market NeuroPort System

... Andrew Gotshalk. "The NeuroPort System enables us to work directly with leading clinicians to develop applications of our technology to monitor, diagnose and treat a wide range of debilitating diseases and conditions that, today, are poorly managed and diagnosed." In March 2009, Blackrock ...

Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010

... Hutchinson Cancer Research Center , our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, ...

MEDomics Announces MitoDx(TM), the First NextGen Mitochondrial Genome Diagnostic Test

... an exceptionally low error rate, allowing detection of heteroplasmy down to about 1%. The MEDomics NextGen mitochondrial genome test can help diagnose mitochondrial disease, enabling life-saving therapy decisions and allowing for accurate family risk counseling. About MEDomics MEDomics ...

Gen-Probe to Webcast Two Upcoming Investor Presentations

... leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 25 years of NAT expertise, and received the 2004 National Medal of Technology, ...

AGA Institute and Horizon Therapeutics Launch 'Connect to Protect' Program to Educate Physicians and Consumers on Risks Associated With NSAID Use

... of two non-profit organizations -- the AGA and the AGA Institute -- our more than 17,000 members include physicians and scientists who research, diagnose and treat disorders of the gastrointestinal tract and liver. The AGA administers all membership and public policy activities, while the AGA Institute ...

Boston Scientific's SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R)

... System. The system is intended to guide visualization and accessory devices throughout the pancreatico-biliary system, enabling physicians to diagnose and treat pancreatic cancer or pre-cancerous tissues. The SpyGlass System is a single-operator system developed to overcome the challenges of ...

SpectraScience CEO Jim Hitchin Featured in Interview With The Wall Street Transcript

... are not diagnosed or caught early enough, result in higher mortality rates and higher costs. Our technology enables physicians to more accurately diagnose these diseases, and to do so at an earlier stage. This is critical to reducing deaths from cancer and to reducing overall costs to the healthcare ...

Ochsner and LSUHSC Partner to Provide Better Local Access to Comprehensive Cancer Care

... "The joint program will allow scientists and clinicians to jointly study the most frequent cancers in our region and design new ways to prevent, diagnose and treat them," notes Dr. Augusto Ochoa, Director of the LSUHSC Stanley S. Scott Cancer Center. "This partnership was developed from mutual ...

Z Therapy Is The First In North Texas To Offer Revolutionary Treatment Option For Neck Pain Sufferers

... Tallon said. "The MCU is a revolutionary step forward in the diagnosis and treatment of whiplash. It allows us to more accurately diagnose and treat each patient with long-term results." For more information on the MCU and other treatment options for whiplash associated ...

Alpine Biomed Opens New Manufacturing Facility to Support Demand for Specialty Diagnostic Devices

... the most advanced technologies that connect our manufacturing centers around the world to provide our customers with the highest-quality devices that diagnose a range of gastrointestinal and neurological disorders." Alpine Biomed's new facility is one of the first U.S.- headquartered companies in ...

Gen-Probe Completes Acquisition of Tepnel Life Sciences

... leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 25 years of NAT expertise, and received the 2004 National Medal of Technology, ...

Immunotherapy-Based Provisional Patents Mark Significant Discovery

... on cancer cells (OFA/iLRP peptides), these antibodies have diagnostic and therapeutic uses. From a diagnostic standpoint, tests can be created to diagnose the presence or location of cancer in serum or in tissue by the addition of marker substances to the antibodies. From a therapeutic standpoint, these ...

Frost & Sullivan Lauds Carl Zeiss Meditec for Dominating the OCT Market for Ophthalmic Applications

... which enable doctors to improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat ophthalmic diseases. In the field of Neuro/ENT surgery the Company provides innovative visualization solutions. Carl Zeiss Meditec's ...

Satyam Wins Consumer Health World Award for Tele-Ophthalmology Program

... in large cities to remote areas. The technology enables ophthalmologists and trained vision technicians from Hyderabad's LV Prasad Eye Institute to diagnose patients in remote locations by virtually viewing their eyelids, conjunctivas, corneas, anterior chambers, irises, pupil reactions and lenses. When ...

Angiotech announces positive results from Bio-Seal(TM) clinical study

... success," said Dr. William Hunter, President and CEO of Angiotech. "These results indicate that Bio-Seal improves the existing technology used to diagnose lung cancer by significantly reducing the rates of pneumothorax." The purpose of this clinical study was to assess the safety and efficacy of an ...

Gen-Probe to Webcast Two Upcoming Investor Presentations

... leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 25 years of NAT expertise, and received the 2004 National Medal of Technology, ...

SleepQuest Continues to Fight for Sleep Apnea Education

... health as nutrition and exercise," said Robert Koenigsberg, President of SleepQuest. "We can give physicians the tools they need to easily screen, diagnose and treat sleep apnea--helping cut the risk of stroke and heart disease associated with chronic sleep loss for more than 30 million Americans." ...

Gen-Probe Borrows $170 Million Under New Line of Credit

... leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 25 years of NAT expertise, and received the 2004 National Medal of Technology, ...

Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock

... About Synvista Therapeutics Synvista Therapeutics is a biopharmaceutical company developing clinical diagnostic laboratory tests to diagnose and facilitate treatment of cardiovascular disease in people with diabetes. The Company has developed a protein-based clinical laboratory test to ...
Other Contents
(Date:12/19/2014)... Dec. 18, 2014  23andMe, Inc., the leading personal ... that pinpoints fine-scale differences in genetic ancestry of individuals ... Since immigrants first arrived more than four ... has served as a meeting place for peoples ... and the ongoing mixing of peoples with African, European, ...
(Date:12/17/2014)... BELVOIR, Va. , Dec. 15, 2014 /PRNewswire-USNewswire/ ... efforts to make it easier to detect and ... chain. Today the agency started performing ... The capability will validate the authenticity of purchased ... chain. The new quality control measures will be ...
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ... "Global Chemical Sensor Market 2015-2019" report to ... One major trend upcoming in ... sensors in biomedical applications. Chemical sensors help in ... diagnosis during surgical procedures. The Global Chemical Sensor ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
(Date:12/22/2014)... 2014 International efforts to ... epidemic are receiving further support from recent ... organizations (NGOs) and other charitable organizations. While ... emergency responders, patients and others can immediately ... CmTP MediDefense system , which includes ...
(Date:12/22/2014)... York, NY (PRWEB) December 22, 2014 ... 2014 stronger than ever, having invested more than ... injured service members, veterans and their families. , ... for nearly a dozen nonprofits, helping with: veteran ... nursing scholarships; and life-coaches for severely injured veterans. ...
(Date:12/22/2014)... Naples, Florida (PRWEB) December 22, 2014 ... this holiday season, the gift of health and vitality. ... is offering its three top-selling anti-aging formulas in special ... with free rush delivery. , Each bottle contains ... digestion, areas that don't work as well as we ...
(Date:12/22/2014)... December 22, 2014 Xarelto Lawsuit ... panel of judges has granted a request to centralize ... U.S. District Court, Eastern District of Louisiana. The U.S. ... on December 12 to transfer over 50 Xarelto cases–21 ... to the Louisiana court for consolidation under U.S. District ...
(Date:12/22/2014)... FL (PRWEB) December 22, 2014 Christmas is ... Beauty® has a fast and easy solution that will please: ... cards can be purchased from from $25 up to $350," ... offer 100% customer satisfaction and a wide array of skin ... no fees and no expiration dates. , Gift delivery ...
Breaking Medicine News(10 mins):Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 4Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 3Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 4Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 6Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 7Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 3Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 4
Other TagsOther Tags